Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832363 · ClinicalTrials.gov registry record · Phase 2
Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI
A Phase 2 study of Asthma, sponsored by Xemed.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01832363 is a Phase 2 study of Asthma that has completed, run by Xemed. The registered enrollment target is 30 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01832363, a Phase 2 study of Asthma, has completed, sponsored by Xemed.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the bronchial thermoplasty treatment can be guided through hyperpolarized xenon lung MRI.
Conditions Studied
Interventions
- DRUG HXe MRI guided treatment sequence for BT
- OTHER Standard treatment sequence for BT (control)
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01832363
The ClinicalTrials.gov registry entry for NCT01832363 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is Xemed, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which HXe MRI guided treatment sequence for BT is the first listed.
NCT01832363 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01832363 about?
NCT01832363 is a clinical study titled "Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI". The purpose of this study is to determine if the bronchial thermoplasty treatment can be guided through hyperpolarized xenon lung MRI.
What is the current status of trial NCT01832363?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2013-03. Estimated completion is 2019-05.
What conditions does trial NCT01832363 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01832363?
The interventions under investigation include: HXe MRI guided treatment sequence for BT (DRUG), Standard treatment sequence for BT (control) (OTHER).
Who is sponsoring clinical trial NCT01832363?
This trial is sponsored by Xemed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01832363 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.